Robust M&A momentum in 2026, fueled by record megadeal volume exceeding $4 trillion year-to-date and concentrated in AI, technology, and energy sectors, underpins trader sentiment for near-term acquisitions. Strong U.S. corporate earnings, healthy balance sheets, and a lenient antitrust environment have supported transformative deals, though Q3 volumes softened amid higher borrowing costs and yield pressures. Cross-border activity remains elevated, with North America dominating value. Key near-term catalysts include Q4 earnings releases, potential regulatory approvals, and sector-specific opportunities in AI infrastructure and biotech, where companies like Perplexity AI and Viking Therapeutics show varying implied probabilities reflecting deal speculation versus execution risks before year-end resolution.